Our findings that PDGFRβ is important for JEV infection and that the approved drug imatinib blocks the infection suggest that an effective repurposing of PDGFRβ inhibitor is a possible treatment strategy for JEV infection. The gene discussed is PDGFRB; the disease is infection.